** Shares of medtech firm Senseonics Holdings SENS.A down a penny post-market to 54 cents as it looks to raise equity
** Germantown, Maryland-based maker of continuous glucose monitoring (CGM) systems commences $50 mln public offering
** Co says Abbott Laboratories ABT.N agreed to buy up to $25 mln of shares in concurrent private placement
** It intends to use net proceeds from both transactions to fund ongoing launch of Eversense 365, and continued development of its pipeline
** TD Cowen and Barclays are jt-lead bookrunners for proposed offering, joined by RBC and Lake Street
** Senseonics has ~654.3 mln shares outstanding and ~585.1 mln shares of free float, per LSEG data
** SENS fell for 5th straight day on Thurs. Stock well off its 52-week high of $1.40 hit in mid-Feb
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.